These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35351598)

  • 21. Primary Immunodeficiencies with Elevated IgE.
    Mogensen TH
    Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperimmunoglobulin E syndromes in pediatrics.
    Zhang Q; Su HC
    Curr Opin Pediatr; 2011 Dec; 23(6):653-8. PubMed ID: 21970826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
    Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
    J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
    Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
    Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal recessive hyper-IgE syndrome successfully treated with hematopoietic stem cell transplantation.
    Lopes J; Teixeira D; Sousa C; Baptista A; Moreira D; Ferreira EO
    Pediatr Dermatol; 2019 Sep; 36(5):693-696. PubMed ID: 31338855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
    Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
    Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
    Oikonomopoulou C; Goussetis E
    Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
    Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
    Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
    Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
    Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
    Tsilifis C; Freeman AF; Gennery AR
    J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of hyper IgE syndrome.
    Heimall J; Freeman A; Holland SM
    Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
    Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
    J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.
    Wu J; Hong L; Chen TX
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):51. PubMed ID: 30112673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency.
    Liquidano-Perez E; Maza-Ramos G; Perez Arias BA; Lugo Reyes SO; Barragan Arevalo T; Solorzano-Morales SA; Venegas Montoya E; Staines-Boone AT; Guzmán Cotaya R; Okada S; Picard C; Patin E; Ramirez-Uribe N; Bustamante-Ogando JC; Scheffler-Mendoza SC; Yamazaki-Nakashimada MA; Saez-de-Ocariz M; Espinosa Padilla SE; Gonzalez-Serrano ME
    Pediatr Allergy Immunol; 2024 Feb; 35(2):e14073. PubMed ID: 38351896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined immunodeficiency due to DOCK8 deficiency. State of the art].
    Liquidano-Pérez E; Maza-Ramos G; Yamazaki-Nakashimada MA; Barragán-Arévalo T; Lugo-Reyes SO; Scheffler-Mendoza S; Espinosa-Padilla SE; González-Serrano ME
    Rev Alerg Mex; 2022 Jul; 69(1):31-47. PubMed ID: 36927749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
    Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W
    Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis.
    Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S
    J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families.
    Guo M; Ma Y; Cai K; Liu X; Liu W; Wang F; Qu N; Liu S
    Immunogenetics; 2024 Jun; 76(3):165-173. PubMed ID: 38587548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
    Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
    J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.